- Home
- CASI vs IDN Comparison
CASI vs IDN Comparison
Compare CASI & IDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CASI
- IDN
- Stock Information
- Founded
- CASI 1991
- IDN 1994
- Country
- CASI China
- IDN United States
- Employees
- CASI N/A
- IDN N/A
- Industry
- CASI Biotechnology: Pharmaceutical Preparations
- IDN Computer Software: Prepackaged Software
- Sector
- CASI Health Care
- IDN Technology
- Exchange
- CASI Nasdaq
- IDN Nasdaq
- Market Cap
- CASI 58.8M
- IDN 53.8M
- IPO Year
- CASI 1996
- IDN 1999
- Fundamental
- Price
- CASI $2.36
- IDN $2.80
- Analyst Decision
- CASI Strong Buy
- IDN Buy
- Analyst Count
- CASI 1
- IDN 3
- Target Price
- CASI $6.00
- IDN $3.33
- AVG Volume (30 Days)
- CASI 30.6K
- IDN 68.4K
- Earning Date
- CASI 11-15-2024
- IDN 03-20-2025
- Dividend Yield
- CASI N/A
- IDN N/A
- EPS Growth
- CASI N/A
- IDN N/A
- EPS
- CASI N/A
- IDN N/A
- Revenue
- CASI $22,055,000.00
- IDN $19,236,000.00
- Revenue This Year
- CASI N/A
- IDN $2.09
- Revenue Next Year
- CASI $134.79
- IDN $8.67
- P/E Ratio
- CASI N/A
- IDN N/A
- Revenue Growth
- CASI N/A
- IDN 5.22
- 52 Week Low
- CASI $2.05
- IDN $1.67
- 52 Week High
- CASI $7.67
- IDN $4.46
- Technical
- Relative Strength Index (RSI)
- CASI 33.52
- IDN 51.87
- Support Level
- CASI $2.27
- IDN $2.67
- Resistance Level
- CASI $2.73
- IDN $2.94
- Average True Range (ATR)
- CASI 0.24
- IDN 0.14
- MACD
- CASI 0.02
- IDN 0.00
- Stochastic Oscillator
- CASI 12.70
- IDN 67.44
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.
About IDN Intellicheck Inc.
Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The company makes it possible for its clients to increase revenues, improve customer service, and increase operational efficiencies. Under the new direction, the company is focused on partnering with banks credit card issuers, and retailers to prevent fraud. It derives revenue through Sales of systems, subscription fees, Sale of software upgrades, and extended maintenance programs.